(Q38208221)

31 August 2017

Insulin resistance, diabetes, and cardiovascular risk (English)

1 reference

31 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781596%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Francesco Cosentino

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781596%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Sarah Costantino

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781596%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

1 reference

1 July 2014

1 reference

Current Atherosclerosis Reports

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781596%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781596%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781596%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781596%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11883-014-0419-z

1 June 2020

exact match

0 references

cites work

Obesity and diabetes in the developing world--a growing challenge

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Body fat distribution and risk of cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Mechanisms linking obesity to insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Mapping body fat distribution: a key step towards the identification of the vulnerable patient?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Joint ESC/EASD guidelines on diabetes, where are we now and where should we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Diabetes and decline in heart disease mortality in US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Strategies to enhance cardiovascular disease prevention in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Insulin resistance, hyperglycemia, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Do diabetes, metabolic syndrome or their association equally affect biventricular function? A tissue Doppler study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Impact of insulin resistance on post-procedural myocardial injury and clinical outcomes in patients who underwent elective coronary interventions with drug-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Insulin resistance and hyperinsulinemia: you can't have one without the other

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Basal insulin and cardiovascular and other outcomes in dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Oxidative stress and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Activation of protein kinase C isoforms and its impact on diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Apoptosis and aging: role of p66Shc redox protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

p66Shc, mitochondria, and the generation of reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

The emerging challenge in diabetes: the "metabolic memory".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Epigenetics: mechanisms and implications for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Insulin status and vascular responses to weight loss in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-β isoform in the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Metformin improves endothelial function in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

The endothelium abridges insulin resistance to premature aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Current concepts on coronary revascularization in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Simple non-invasive assessment of advanced glycation endproduct accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Role of microRNAs in diabetes and its cardiovascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

MicroRNAs in vascular and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Plasma endothelial microparticles and their correlation with the presence of hypertension and arterial stiffness in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0419-Z

Monoclonal-antibody pd-41 recognizes a prostate-cancer associated antigen whose expression increases in metastases and following hormonal-therapy.

21 January 2018

1 reference

12 December 2020

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

12 December 2020

An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study

1 reference

12 December 2020

Involvement of microparticles in diabetic vascular complications

1 reference

12 December 2020

The complex metabolic mechanisms relating obesity to hypertriglyceridemia

1 reference

12 December 2020

Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.

1 reference

12 December 2020

Blockade of the nuclear factor-κB pathway in the endothelium prevents insulin resistance and prolongs life spans

1 reference

12 December 2020

Advanced glycation endproducts and plaque instability: a link beyond diabetes

1 reference

12 December 2020

Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy

1 reference

12 December 2020

Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy

1 reference

12 December 2020

The clinical relevance of dysfunctional HDL in patients with coronary artery disease: A 3-year follow-up study

1 reference

12 December 2020

Endothelial nuclear factor κB in obesity and aging: is endothelial nuclear factor κB a master regulator of inflammation and insulin resistance?

1 reference

12 December 2020

Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle

1 reference

12 December 2020

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe

1 reference

12 December 2020

Tetrahydrobiopterin and endothelial nitric oxide synthase activity

1 reference

12 December 2020